期刊论文详细信息
Rheumatology and Therapy 卷:6
A Summary of 2018 and What Lies Ahead for Rheumatology and Therapy in 2019
Roy Fleischmann1 
[1] Metroplex Clinical Research Center, University of Texas Southwestern Medical Center;
关键词: Biosimilars;    Gout;    JAK inhibitors;    Osteoarthritis;    Psoriatic arthritis;    Rheumatoid arthritis;   
DOI  :  10.1007/s40744-018-0136-0
来源: DOAJ
【 摘 要 】

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:0次